Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticancer drug targets: approaching angiogenesis.

× No keyword cloud information.

27 in total

Review 1. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

Authors: B P Eliceiri; D A Cheresh
Journal: J Clin Invest Date: 1999-05 Impact factor: 14.808

Review 2. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

Authors: N W Gale; G D Yancopoulos
Journal: Genes Dev Date: 1999-05-01 Impact factor: 11.361

3. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

Authors: G Bergers; K Javaherian; K M Lo; J Folkman; D Hanahan
Journal: Science Date: 1999-04-30 Impact factor: 47.728

4. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.

Authors: I Vlodavsky; Y Friedmann; M Elkin; H Aingorn; R Atzmon; R Ishai-Michaeli; M Bitan; O Pappo; T Peretz; I Michal; L Spector; I Pecker
Journal: Nat Med Date: 1999-07 Impact factor: 53.440

Review 5. Tumor angiogenesis: therapeutic implications.

Authors: J Folkman
Journal: N Engl J Med Date: 1971-11-18 Impact factor: 91.245

6. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.

Authors: M Ohh; Y Takagi; T Aso; C E Stebbins; N P Pavletich; B Zbar; R C Conaway; J W Conaway; W G Kaelin
Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808

7. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors: D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal: Proc Natl Acad Sci U S A Date: 1990-09 Impact factor: 11.205

8. Anti-cancer activity of targeted pro-apoptotic peptides.

Authors: H M Ellerby; W Arap; L M Ellerby; R Kain; R Andrusiak; G D Rio; S Krajewski; C R Lombardo; R Rao; E Ruoslahti; D E Bredesen; R Pasqualini
Journal: Nat Med Date: 1999-09 Impact factor: 53.440

9. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Authors: J Holash; P C Maisonpierre; D Compton; P Boland; C R Alexander; D Zagzag; G D Yancopoulos; S J Wiegand
Journal: Science Date: 1999-06-18 Impact factor: 47.728

10. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors: A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal: Am J Pathol Date: 1999-09 Impact factor: 4.307

18 in total

1. Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.

Authors: Bryan T Oronsky; Jan J Scicinski; Tony Reid; Susan Knox
Journal: Transl Oncol Date: 2012-06-01 Impact factor: 4.243

2. Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein.

Authors: Dabin Liu; Chen Wang; Cun Li; Xin Zhang; Baozhong Zhang; Zhiqiang Mi; Xiaoping An; Yigang Tong
Journal: J Biol Chem Date: 2011-05-23 Impact factor: 5.157

3. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.

Authors: A Maataoui; J Qian; D Vossoughi; M F Khan; E Oppermann; W O Bechstein; T J Vogl
Journal: Eur Radiol Date: 2004-12-04 Impact factor: 5.315

4. IL-1 is required for tumor invasiveness and angiogenesis.

Authors: Elena Voronov; Dror S Shouval; Yakov Krelin; Emanuela Cagnano; Daniel Benharroch; Yoichiro Iwakura; Charles A Dinarello; Ron N Apte
Journal: Proc Natl Acad Sci U S A Date: 2003-02-21 Impact factor: 11.205

Review 5. Combined interventional therapies of hepatocellular carcinoma.

Authors: Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal: World J Gastroenterol Date: 2003-09 Impact factor: 5.742

6. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.

Authors: Qi-Hong Zhao; Ying Zhang; Yun Liu; Hui-Li Wang; Yuan-Yuan Shen; Wen-Jun Yang; Long-Ping Wen
Journal: Med Oncol Date: 2009-03-12 Impact factor: 3.064

7. Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis.

Authors: Amanda G Linkous; Eugenia M Yazlovitskaya; Dennis E Hallahan
Journal: J Natl Cancer Inst Date: 2010-08-20 Impact factor: 13.506

8. Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors: Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal: Sensors (Basel) Date: 2009-08-20 Impact factor: 3.576

9. Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis.

Authors: Amy L Bauer; Trachette L Jackson; Yi Jiang
Journal: PLoS Comput Biol Date: 2009-07-24 Impact factor: 4.475

10. A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors.

Authors: Fen Wang; Julian Molina; Daniel Satele; Jun Yin; Vun-Sin Lim; Alex A Adjei
Journal: Invest New Drugs Date: 2018-10-31 Impact factor: 3.651